Literature DB >> 28685447

Diet-Induced Ketosis Protects Against Focal Cerebral Ischemia in Mouse.

Kui Xu1, Lena Ye1, Katyayini Sharma1, Yongming Jin2, Matthew M Harrison1, Tylor Caldwell1, Jessica M Berthiaume1, Yu Luo2, Joseph C LaManna1, Michelle A Puchowicz3.   

Abstract

Over the past decade we have consistently shown that ketosis is neuroprotective against ischemic insults in rats. We reported that diet-induced ketotic rats had a significant reduction in infarct volume when subjected to middle cerebral artery occlusion (MCAO), and improved survival and recovery after cardiac arrest and resuscitation. The neuroprotective mechanisms of ketosis (via ketogenic diet; KG) include (i) ketones are alternate energy substrates that can restore energy balance when glucose metabolism is deficient and (ii) ketones modulate cell-signalling pathways that are cytoprotective. We investigated the effects of diet-induced ketosis following transient focal cerebral ischemia in mice. The correlation between levels of ketosis and hypoxic inducible factor-1alpha (HIF-1α), AKT (also known as protein kinase B or PKB) and 5' AMP-activated protein kinase (AMPK) were determined. Mice were fed with KG diet or standard lab-chow (STD) diet for 4 weeks. For the MCAO group, mice underwent 60 min of MCAO and total brain infarct volumes were evaluated 48 h after reperfusion. In a separate group of mice, brain tissue metabolites, levels of HIF-1α, phosphorylated AKT (pAKT), and AMPK were measured. After feeding a KG diet, levels of blood ketone bodies (beta-hydroxyburyrate, BHB) were increased. There was a proportional decrease in infarct volumes with increased blood BHB levels (KG vs STD; 4.2 ± 0.6 vs 7.8 ± 2.2 mm3, mean ± SEM). A positive correlation was also observed with HIF-1α and pAKT relative to blood BHB levels. Our results showed that chronic ketosis can be induced in mice by KG diet and was neuroprotective against focal cerebral ischemia in a concentration dependent manner. Potential mechanisms include upregulation of cytoprotective pathways such as those associated with HIF-1α, pAKT and AMPK.

Entities:  

Keywords:  HIF-1α, AKT; Ischemia-reperfusion injury; Ketogenic diet; Neuroprotection.

Mesh:

Substances:

Year:  2017        PMID: 28685447     DOI: 10.1007/978-3-319-55231-6_28

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Modulation of cerebral ketone metabolism following traumatic brain injury in humans.

Authors:  Adriano Bernini; Mojgan Masoodi; Daria Solari; John-Paul Miroz; Laurent Carteron; Nicolas Christinat; Paola Morelli; Maurice Beaumont; Samia Abed-Maillard; Mickael Hartweg; Fabien Foltzer; Philippe Eckert; Bernard Cuenoud; Mauro Oddo
Journal:  J Cereb Blood Flow Metab       Date:  2018-10-24       Impact factor: 6.200

Review 2.  Adenosine and Ketogenic Treatments.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  J Caffeine Adenosine Res       Date:  2020-09-16

Review 3.  New Insights into Stroke Prevention and Treatment: Gut Microbiome.

Authors:  Linna Zhao; Liji Yang; Yuying Guo; Jie Xiao; Junping Zhang; Shixin Xu
Journal:  Cell Mol Neurobiol       Date:  2021-02-26       Impact factor: 5.046

4.  Looking for CO2: Exploring the Novel Finding of Low Respiratory Quotient After Cardiac Arrest.

Authors:  Katherine M Berg; Michael W Donnino; Clifton Callaway
Journal:  J Am Heart Assoc       Date:  2018-06-29       Impact factor: 5.501

5.  Ingested Ketone Ester Leads to a Rapid Rise of Acetyl-CoA and Competes with Glucose Metabolism in the Brain of Non-Fasted Mice.

Authors:  Laurent Suissa; Pavel Kotchetkov; Jean-Marie Guigonis; Emilie Doche; Ophélie Osman; Thierry Pourcher; Sabine Lindenthal
Journal:  Int J Mol Sci       Date:  2021-01-07       Impact factor: 5.923

6.  Nerve injury and repair in a ketogenic milieu: A systematic review of traumatic injuries to the spinal cord and peripheral nervous tissue.

Authors:  Jamasb Joshua Sayadi; Lohrasb Sayadi; Ellen Satteson; Mustafa Chopan
Journal:  PLoS One       Date:  2021-01-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.